News | Robotic Systems | September 22, 2017

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery

da Vinci Xi robot is also designed for coronary artery bypass surgery

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery

September 22, 2017 — The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and the first in Canada to be exclusively dedicated to cardiac surgery. "The development of robotic cardiac surgery plays a major role in the expansion of minimally invasive surgery, whose purpose is to minimize the trauma endured by the body by reducing the incision size, for instance", according to the surgical team counting among its members Michel Pellerin, M.D., and Denis Bouchard, M.D., the two cardiac surgeons who performed the first robotic mitral intervention last April. "This new technology will improve the patients' quality of life and allow for a faster return to daily activity, among other benefits", they continued.

The mitral valve repair program was first initiated at the MHI in 1995; back then, the program used a more conventional approach of median sternotomy. More than 2,500 cases were performed using that approach. In 2006, this program evolved to minimally invasive surgery, where a small incision on the right side of the thorax is performed. Approximately 900 surgeries were performed using this innovative approach. Today, in 2017, the evolution of the mitral valve repair program is intrinsically connected to robotic surgery, the ultimate step.

"We need to keep in mind that robotic surgery is an evolving field; the acquisition of this robot will allow us to remain at the spearhead of this type of cardiac surgery", according to Mélanie La Couture, Montreal Heart Institute chief executive officer.

The new da Vinci Xi surgical robotic equipment consists of three main components: a robot acting as remote manipulator, a control console used by the surgeon and an endoscopic vision cart allowing for perfect 3-D visualization. "With this highly sophisticated new technology, our surgeons can now rely on better-performing instruments to have more precise hand gestures and an enhanced view thanks to 3D visualization", continued Louis P. Perrault, M.D., Ph.D, head of the Department of Cardiac Surgery at MHI. Since the surgeon is in permanent control of the robot, this is robot-assisted cardiac surgery.

The acquisition of this robot was made possible thanks to the generous donors of the Montreal Heart Institute Foundation.

For more information:

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems| December 08, 2017
December 7, 2017 — Stereotaxis Inc.
Edwards Acquires Harpoon Medical
News | Heart Valve Technology| December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System
News | Robotic Systems| December 06, 2017
December 6, 2017 — French company Robocath, which designs and develops...
Studies find 15 percent of all heart attack and stroke patients and 9 percent of CABG patients were uninsured before passage of the Affordable Care Act. AHA 2017, #aha2017
News | November 25, 2017
November 25, 2017 — The majority of patients without health insurance who were hospitalized for heart attack, stroke
Surgery Could Reduce Frailty in Adults With Heart Failure
News | Heart Failure| November 17, 2017
November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with surge
Videos | 3-D Printing| November 17, 2017
Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses
German Hospital Plans Life-Saving Vascular Surgeries With 3-D Printing

Transparent Stratasys 3-D-printed model of a patient-specific aortic arch, used by the University Hospital Mainz to practice complex endovascular surgeries. Photo courtesy of Business Wire.

News | 3-D Printing| November 16, 2017
Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular Surgery Department in...
Videos | Heart Valve Technology| November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | TCT| November 09, 2017
November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has select
Overlay Init